ClinicalTrials.Veeva

Menu

Inflammation in Type 2 Myocardial Infarction

NYU Langone Health logo

NYU Langone Health

Status

Withdrawn

Conditions

Inflammation
Critical Illness
Myocardial Infarction

Study type

Observational

Funder types

Other

Identifiers

NCT02385487
S14-01349

Details and patient eligibility

About

Type 2 myocardial infarction (MI) is defined as myocardial necrosis that results from an imbalance of myocardial oxygen supply and demand. Although type 2 MI is highly prevalent in patients with critical illness and strongly associated with mortality, the pathophysiology remains poorly understood. Inflammation is central to the development of atherosclerosis, plaque rupture, and other subtypes of MI, but the role of inflammation in type 2 MI and myocardial necrosis has not been defined. The investigators aim to to delineate the mechanistic role of inflammation in myocardial necrosis and type 2 MI complicating critical medical illness.

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥21 years of age
  • admitted to the Medical Intensive or Coronary Care Units
  • sepsis or respiratory failure
  • clinically indicated troponin measurement within 24 hours of ICU admission

Exclusion criteria

  • unstable angina or Type 1 MI
  • percutaneous or surgical coronary revascularization within 7 days
  • heart failure exacerbation
  • primary valvular disorder
  • aortic dissection
  • infiltrative heart disease or hypertrophic cardiomyopathy
  • myocarditis
  • pulmonary embolism
  • electrocardiogram with >1mm ST segment elevation in two consecutive leads
  • serum cardiac troponin >99th percentile URL but no clear rise or fall pattern
  • history of chronic inflammatory disease
  • use of therapeutic-dose anticoagulants / antiplatelet agents other than aspirin
  • pregnant or incarcerated
  • enrolled in a competing study

Trial design

0 participants in 2 patient groups

Critical illness and type 2 MI
Description:
Critically ill adults with abnormal serum troponin I during hospitalization for critical illness.
Critical illness without type 2 MI
Description:
Critically ill adults without an elevation in troponin I complicating critical illness.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems